Development and Characterization of Liposomal Formulations Containing Phytosterols Extracted from Canola Oil Deodorizer Distillate along with Tocopherols as Food Additives by Poudel, Asmita et al.
pharmaceutics
Article
Development and Characterization of Liposomal
Formulations Containing Phytosterols Extracted
from Canola Oil Deodorizer Distillate along with
Tocopherols as Food Additives
Asmita Poudel, George Gachumi, Kishor M. Wasan, Zafer Dallal Bashi, Anas El-Aneed *
and Ildiko Badea *
Drug Design and Discovery Group, College of Pharmacy and Nutrition, University of Saskatchewan,
107 Wiggins Road, Saskatoon, SK S7N 5E5, Canada; asp170@mail.usask.ca (A.P.);
george.gachumi@usask.ca (G.G.); kishor.wasan@usask.ca (K.M.W.); zafer.bashi@usask.ca (Z.D.B.)
* Correspondence: anas.el-aneed@usask.ca (A.E.); ildiko.badea@usask.ca (I.B.);
Tel.: +1-306-966-2013 (A.E.); +1-306-966-6349 (I.B.)
Received: 28 February 2019; Accepted: 9 April 2019; Published: 16 April 2019


Abstract: Phytosterols are plant sterols recommended as adjuvant therapy for hypercholesterolemia
and tocopherols are well-established anti-oxidants. However, thermo-sensitivity, lipophilicity and
formulation-dependent efficacy bring challenges in the development of functional foods, enriched
with phytosterols and tocopherols. To address this, we developed liposomes containing brassicasterol,
campesterol and β-sitosterol obtained from canola oil deodorizer distillate, along with alpha,
gamma and delta tocopherol. Three approaches; thin film hydration-homogenization, thin film
hydration-ultrasonication and Mozafari method were used for formulation. Validated liquid
chromatographic tandem mass spectrometry (LC-MS/MS) was utilized to determine the entrapment
efficiency of bioactives. Stability studies of liposomal formulations were conducted before and after
pasteurization using high temperature short time (HTST) technique for a month. Vesicle size after
homogenization and ultrasonication (<200 nm) was significantly lower than by Mozafari method
(>200 nm). However, zeta potential (−9 to −14 mV) was comparable which was adequate for colloidal
stability. Entrapment efficiencies were greater than 89% for all the phytosterols and tocopherols
formulated by all three methods. Liposomes with optimum particle size and zeta potential were
incorporated in model orange juice, showing adequate stability after pasteurization (72 ◦C for 15 s)
for a month. Liposomes containing phytosterols obtained from canola waste along with tocopherols
were developed and successfully applied as a food additive using model orange juice.
Keywords: phytosterols; tocopherols; liposomes; canola oil deodorizer distillate; model orange juice
1. Introduction
Functional foods and nutraceuticals are increasing rapidly due to growing consumer preferences
towards natural bioactives rather than synthetic drugs for disease prevention and treatment [1].
Phytosterols and tocopherols are such bioactives (plant metabolites) that have numerous health
claims [2,3]. The primary health benefit of phytosterols is to lower low-density lipoprotein (LDL)
cholesterol levels in plasma [2,4,5]. Due to this health claim, the National Cholesterol Education
Program Adult Treatment Panel III (NCEP ATP III) has recommended phytosterols as adjuvant therapy
to statins in hypercholesterolemia [6]. Phytosterols compete with cholesterol for their solubilization
in bile salt micelles, hindering the absorption of cholesterol in blood [7,8]. Tocopherols, on the other
hand, are free radical scavengers and natural anti-oxidants [9,10]. Due to their anti-oxidant properties,
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tocopherols are used in the treatment of age related macular degeneration [11], Alzheimer’s disease [12],
glaucoma [3] and heart diseases [13].
Sources of phytosterols and tocopherols include oil seeds such as canola and sesame, as well as
nuts [14–16]. Among these, canola is a major source for edible vegetable oils, and the most abundant
oilseed crop in Canada [17]. It is a rich source of four phytosterols, namely beta-sitosterol, campesterol,
stigmasterol and brassicasterol, and four tocopherols (alpha, beta, gamma and delta) [16,18]. Canola oil
loses some of its valuable components during the refining process [16]. Significant amount of
phytosterols and tocopherols are transferred to the waste stream, termed canola oil deodorizer distillate
(CODD) [16] which offers an ideal source of these components.
However, formulation of these bioactives in functional foods has always been challenging due to
their lipophilicity and light sensitivity [19]. In particular, degradation products of phytosterols,
phytosterol oxidation products (POPs), are known to have some negative impact on human
health [20,21]. Thus, the selection of suitable formulation approach is crucial during the development
of functional food that contain these bioactives. Encapsulation techniques, such as spray drying,
fluidized bed coating, microemulsification and liposomal entrapment are emerging in the food industry
to address lipophilicity related challenges [22,23]. Unfortunately, most of these techniques have
shortcomings such as usage of high temperature (can possibly degrade phytosterols and tocopherols)
and the requirement of large quantities of emulsifiers and surfactants, which are deleterious to human
health [23–27]. All of these shortcomings can be addressed by employing liposomal formulations that
require low heat and low quantities of surfactants or emulsifiers [28].
Phytosterols in both the free and esterified forms have been used in the food industry [2,4].
Solubilization of esterified phytosterols in fat containing foods, like margarine [29,30], salad dressing [31]
and yogurt [32] is prevalent in the food industry. However, this approach is not favorable to people
who are on low fat diet [33]. To overcome this, various low fat or non-fat food matrices such as
low fat milk [34,35], granola bars [36], orange juice [37] and non-fat beverages [38–40] are emerging
as food products. However, for these type of food products, lipophilic phytosterols should be well
formulated prior to their development into functional food. In addition to the choice of the food matrix,
the biological efficacy should also be carefully considered.
Various clinical trials have shown that the efficacy of phytosterols depends on different parameters,
such as solubility in the food matrix and the formulation [2,41]. Esterified phytosterols solubilized
in fat/oil are driven favorably towards the bile salt micelles in the guts than the crystalline or the
insolubilized forms [42,43]. Phytosterols ester containing food products such as milk, spread and
yogurt have showed reduction in LDL-cholesterol by 7–12% at daily dose of 1.6–2 g relative to
control research participants [44–46]. In contrast, some failed clinical trials are also prevalent [47,48].
For example, Ottestad et al. showed that phytosterol ester in the capsular formulation revealed
no significant reduction of LDL cholesterol [47]. Similarly, Denke et al. showed no significance in
cholesterol reduction by sitostanol capsule relative to control [48]. Unlike phytosterol capsule-based
trials, lecithin-based free phytosterol formulations have shown to impart efficacy as high as 14.3% at
a daily dose of only 1.9 g relative to control [39]. In sum, literature reports show that the efficacy of
phytosterols depends greatly on the formulation approach, which provides insights regarding the
possibility of further enhancing their efficacy by well formulating in suitable delivery systems.
The work of Shin at al. [38] and Spilburg at al. [39] provides a strong evidence that lecithin
(phosphatiylcholine) can be effective carrier of phytosterols to increase cholesterol-lowering efficacy.
Both of these studies used lecithin micelles to formulate sterol/stanol which have shown promising
cholesterol-lowering efficacy [38,39]. Liposomes, which have same building blocks as micelles that
is lecithin (i.e., phosphatidylcholine) but different architecture are another formulation strategy in
which lecithin can be utilized, thus have potential of further enhancing its cholesterol-lowering efficacy.
In addition, liposomes can prevent oxidation of thermo-sensitive bioactives and are biocompatible
and biodegradable [49]. Further, co-formulation of tocopherols along with phytosterols can enhance
oxidative stability of phytosterols [50].
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Thus, in this work, with the aim of enhancing phytosterols’ oxidative stability and increasing its
efficacy, we formulated phytosterols (obtained from CODD) and commercially available tocopherols
into liposomes employing three different approaches, namely thin film hydration homogenization,
thin film hydration ultra-sonication and Mozafari method. The liposomal formulation showing
the highest entrapment efficiency, adequate size and zeta potential was incorporated into model
orange juice (acidified solution). Thus, functional orange juice containing liposomal phytosterols and
tocopherols was developed and its stability was assessed.
2. Materials
Chemicals and Reagents
Phytosterols were extracted from CODD obtained from LDM foods (Yorkton, SK, Canada). Briefly,
5 g of CODD was saponified with 1 M potassium hydroxide in 95% ethanol for 1 h at 65 ◦C after
which water was added and the mixture was chilled at 9.5 ◦C for 1 h. After the crystallization of
phytosterols, vacuum filtration was performed and the residue was washed before being dried under
high vacuum. Tocopherols, chloroform, ethyl acetate and potassium hydroxide were purchased from
Sigma Aldrich (Oakville, ON, Canada), and phosphatidylcholine (PC) was purchased from Avanti
Polar Lipids (Alabaster, AL, USA). Purified water was obtained from Millipore (Bedford, MA, USA).
3. Methods
3.1. Formulation of Liposomes
Three different formulation techniques namely thin film hydration homogenization; thin film
hydration ultrasonication and Mozafari method were used for formulation in order to evaluate the
formulation technique that can produce liposomes with optimum physicochemical properties for both
oral delivery and industrial scale up.
3.1.1. Method I. Thin Film Hydration–Homogenization
This method was adopted from Chung et al. [51] with some modifications. In brief, tocopherols
(alpha, gamma and delta tocopherol), phytosterols mixture (brassicasterol, campesterol and
beta-sitosterol) and PC were dissolved in 5 mL ethyl acetate (food grade) in 0.1:0.9:2, 0.1:0.9:3,
0.1:0.9:4 and 0.1:0.9:5 ratio of tocopherol: phytosterol: PC. Ethylacetate was evaporated using rotary
evaporator at pressure of 90 mmHg. The thin lipid film containing bioactives and PC formed on the
wall of the flask was lyophilized for 10 h to remove traces of ethylacetate and was hydrated with 20 mL
of purified water for 3 h at 55◦C with occasional vortexing in the presence of glass beads. The lipid
dispersion was homogenized using recirculating high fluid pressure homogenizer (Microfluidics
Corporation, Westwood, MA, USA) at 60 psi for 20 min. The prepared liposomes were left overnight at
4 ◦C prior to size analysis.
3.1.2. Method II: Thin Film Hydration Ultrasonication
This method was adopted from Akbarzadeh et al. [52]. Similar to thin film hydration
homogenization; tocopherols (alpha, gamma and delta tocopherol), phytosterols mixture (brassicasterol,
campesterol and beta-sitosterol) were dissolved, along with PC in 5 mL ethyl acetate, in 0.1:0.9:2 ratio
of tocopherols: phytosterols: PC. Ethylacetate was evaporated using rotary evaporator at pressure
of 90 mmHg. Thin lipid film containing bioactives and PC was formed at the bottom of the flask.
Lipid film was lyophilized for 10 h to remove traces of ethylacetate and was hydrated with 20 mL of
purified water maintained at 55◦C. Lipid dispersion was ultrasonicated using bath sonicator (ELMA
Corp.,Singen, Germany) for 30 min maintained at 55 ◦C then was allowed to cool at room temperature.
The prepared liposomes were left overnight at 4 ◦C prior to size analysis.
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3.1.3. Method III: Mozafari Method
This method was adopted from Colas et al. [53]. 50 mg of PC was hydrated with 20 mL of purified
water for 1 h and was heated to 55 ◦C. Nine mg of the phytosterol mixture and 1 mg of the tocopherol
mixture were heated with 3% v/v glycerol at 110 ◦C and 55 ◦C temperature, respectively for 15 min
on a hot plate stirrer at approximately 1000 RPM (Corning Corporation, Midland, ON, Canada) and
then was cooled down to 55 ◦C. PC dispersion, phytosterols and tocopherols were mixed together
with stirring on a hot plate for 30 min at approximately 1000 RPM. The formed liposomes were cooled
down to room temperature and kept overnight at 4 ◦C prior to size analysis.
3.2. Characterization of Particle Size, Size Distribution and Zeta Potential
Particle size and zeta potential measurement of the liposomes were performed using Zeta sizer,
Nano ZS instrument, Malvern instruments Ltd. (Worcestershire, England). All measurements were
conducted in triplicates at 25 ◦C and reported as mean ± SD.
3.3. Transmission Electron Microscopy (TEM) Analysis
TEM analysis was performed by negative staining. Briefly, a drop of liposomal sample was placed
on copper- formvar coated TEM grid and was allowed to settle on grid surface for 1 min. Excess of the
liquid was removed using absorbent tissue. Staining of grid was done using 0.5% phosphotungstic
acid for 30 s and excess of stain is removed. Imaging was done using aHT 7700 TEM (Hitachi, Japan)
at 80 kV.
3.4. LC-MS/MS Method Development and Validation
LC-MS/MS method was developed and was validated as per International Council for
Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidance
for bioanalytical method validation guideline [54]. Briefly, chromatographic separation of the analytes
was carried out on an Agilent Acquity UPLC (Agilent Technologies, Mississauga, ON, Canada) with an
Agilent Poroshell C18 column (2.1 mm× 150 mm, 5µm) protected by a guard column (2.1 mm × 4.7 mm,
2.7 µm) of the same packing material. The column temperature was set at 30 ◦C and the injection
volume was 2.5 µL. An isocratic elution consisting of acetonitrile: methanol (99:1 v/v) with 0.1% acetic
acid was used at a flow rate of 0.8 mL/min. The detection and quantification were performed using
an API 6500 QTRAP® quadruple-linear ion trap (QqQ-LIT) mass spectrometer equipped with an
atmospheric pressure chemical ionization (APCI) source obtained from AB Sciex(Mississauga, ON,
Canada). The instrument was operated in the positive ion mode and tandem mass spectrometric
analysis (MS/MS) was employed using the following interface parameters: source temperature 380 ◦C,
curtain gas 30 psi (gas), nebulizer current 2.5 µA, declustering potential 30 V and an ion source gas1
30 psi (gas) [55].
The parameters, selectivity, accuracy, precision, reproducibility, sensitivity, matrix effects, dilution
integrity, stability were assessed [55]
3.5. Entrapment Efficiency (EE)
In order to determine entrapment efficiency, free and entrapped bioactives were separated using
ultracentrifugation. Ultracentrifuge (Beckman coulter, Inc., Indianapolis, IN, USA) with rotor SW 60Ti
was used for ultracentrifugation. Briefly, 5 mL of liposomes was ultracentrifuged at 30, 60, 90 and 120 min
at constant RPM 32,000 (G-force of 138000). The sediment at each time were analyzed using a validated
LC-MS/MS method to optimize ultracentrifugation parameters. The liposomes (present in sediment)
separated by ultracentrifugation were lyophilized using freeze dryer for 24 h. Similar lyophilization
process was employed with 5 mL of unseparated liposomes for 24 h. Dried unseparated and separated
liposomes were dissolved in 2 mL of chloroform separately. Aliquot of each were spiked with internal
standard and diluted with acetonitrile. Samples were injected in LC-MS along with freshly prepared
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calibration and quality control standards, as described [55]. The entrapment efficiency was calculated
by measuring the ratio of entrapped bioactives in the formulation to the total bioactives present in the
formulation and was determined using following equation:
%Entrapment efficiency =
E bioactives
T bioactives
× 100 (1)
where, E bioactives = Entrapped bioactives in liposomes (present in sediment of separated liposomes);
T bioactives = Total bioactives in liposomes (present in unseparated liposomes).
3.6. Development of Functional Juice Using Model Orange Juice
In order to preserve particle size during freeze drying, sucrose was added to liposomes as a
cryoprotectant by adopting the procedure of Shaikh et al. [56]. Briefly, 5% w/v of sucrose was added to
liposomes of well-defined size and was vortexed. Lyophilization then was employed for 24 h.
Freeze dried liposomes were re-suspended in model orange juice which is an orange juice mimic
at 3.2 pH. A mimic was used instead of real orange juice to enable particle size analysis without the
interference of particulate components existing in the orange juice. In fact, the acidified solution is
considered a model juice and was prepared by using acetic acid as per the protocol of Marsansco
et al. [57]. This protocol can be applied for fruit juice with a pH less than 5.0, such as orange juice
and pineapple juice. Finally, liposomes with optimum entrapment efficiency in a dried form were
incorporated into the model orange juice by vortexing for 5 min.
3.7. Pasteurization
High temperature short time (HTST) pasteurization technique was employed as described [58].
HTST is a commonly used strategy for the pasteurization of juice [59]. The liposomes containing model
orange juice was pasteurized at 72 ◦C for 15 s. Unpasteurized formulation was used as a control.
Both pasteurized and unpasteurized model juice were stored at 4 ◦C for stability evaluation.
3.8. Chemical Stability Studies
Both pasteurized and non-pasteurized model juice containing liposomal bioactives were analyzed
using LC-MS/MS to assess the degradation of bioactive upon exposure to pasteurization temperature.
Briefly, 5 mL each of pasteurized and non-pasteurized liposomal model juice were lyophilized.
Dried sample were dissolved in chloroform and were diluted with acetonitrile for LC-MS/MS analysis.
The LC-MS/MS response was compared to obtain relative quantification data.
3.9. Physical Stability Studies
Physical stability evaluation was conducted at the interval of 7 days for a month. Particle size of
pasteurized and non-pasteurized liposomes incorporated both in model orange juice were analyzed.
4. Statistical Analysis
The statistical analysis of the samples was conducted with SPSS statistical software version 24
(SPSS Inc., Chicago, IL, USA) using student t-test, and p-values < 0.05 were considered statistically
significant. All data are reported as means ± standard deviations.
5. Results and Discussions
5.1. Physicochemical Characterization
Size is an important parameter to assess the stability, the biological fate and the efficacy of
formulated bioactives [60,61]. Optimization of bioactive to lipid weight ratio (B/L ratio) was performed
at ratio of 1:5, 1:4. 1:3, 1:2, 1:1 using liposomes prepared by thin film hydration- homogenization
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approach. An increase in particle size was observed at high B/L ratio (1:1) as shown in Figure 1.
At 1:5 B/L ratio, the particle size was 149.53 nm; however, when B/L ratio increased to 1:1, the particle size
increased to 258.31 nm (Figure 1). This observation is reported previously [62,63], in which incremental
vesicle size was observed when increasing the cholesterol (a sterol) concentration. While 1:1 ratio is
preferable from a commercial point of view (less PC required for formulation), smaller particle size
(less than 200 nm) attained at 1:2 ratio, is optimum for liposomal stability. This optimum vesicle size
(less than 200 nm) is consistent with several food-based liposomes [64–66]. Thus, 1:2 B/L ratio was
selected for follow-up experiments. Same optimum B/L ratio was selected for thin-layer ultrasonication
approach. However, in case of the Mozafari method, B/L higher than 1:5 led to the appearance of
visible white precipitate. Loading techniques along with the preparation procedures are found to
influence drug/lipid ratio of liposomes [67]. In both thin film hydration homogenization and thin
film hydration ultrasonication, hydrated bioactives-PC film is subjected to cavitation and shearing
forces unlike the Mozafari method where less intense magnetic stirring is used during the loading
process. This might have led to differences in the B/L ratio of the mozafari method in comparison with
ultrasonication and homogenization methods. In this way, 1:5 B/L as optimum ratio was selected for
formulations prepared by the Mozafari method.
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The co parison f t t e differe t for ulation strategies is presented in Table 1.
Thin film hydration h mogenization and thin film hydration ultrasonication were comparable, showing
sizes at 186.33 ± 4.3 nm and 196.2 ± 16.1 nm, respectively. On th other hand, the size was signific ntly
lar er in the c se of the Mozafari method (260 ± 22.98 nm). It is possible that the high s ar force
and cavitation involved in size re uction during the homogenization and ultrasonication methods is
the reason for the obtained smaller vesicles [68]. The Mozafari method uses a less intense magnetic
stirring [69], probably yielding larger particles. Polydispersibility index (PDI) shown in Table 1 was
found to be in the range from 0.29 to 0.37, which shows the desirable narrow size distribution for
all formulations.
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Table 1. Average particle size (nm), polydispersibility index and zeta potential (mv) of
liposomes prepared by thin film hydration homogenization, thin film hydration ultrasonication
and Mozafari method expressed as mean ± standard deviation where * represents statistical significant
(*p < 0.05) in average particle size of Mozafari method in comparison with homogenization and
ultrasonication method.
Formulation Techniques Average Particle Size (nm) Polydispersibility Index (PDI) Zeta Potential (mV)
Thin film hydration
Homogenization 186.3 ± 4.4 0.370 ± 0.001 −13.0 ± 5.0
Thin film hydration
ultra-sonication 196.2 ± 16.1 0.294 ± 0.084 −14.0 ± 3.4
Mozafari method 260.0 ± 23.0* 0.348 ± 0.087 −9.8 ± 0.3
Zeta potential (surface charge) is another important parameter that determines the stability of
liposomal dispersions [70]. All the liposomes, demonstrated similar zeta potential values (Table 1),
that is in the range of -9 mV to -14 mV, indicating relatively stable systems [71]. Thus, based on
particle size and zeta potential, the developed liposomal formulations are theoretically stable that was
confirmed experimentally by conducting the stability studies.
Finally, TEM analysis of liposomes shows spherical shaped particles with a single lipid bilayer
(Figure 2), representing the expected morphology of unilamellar liposomal vesicles (ULV) [72,73].
The size of approximately 200 nm is consistent with the size range measured by dynamic light scattering
(DLS) (Table 1). Some aggregated particles were observed in ultra-sonication and Mozafari method as
shown in Figure 2.
5.2. Entrapment Efficiency (%EE)
The developed LC-MS/MS method (representative chromatogram shown in Figure 3) was able to
separate and quantify four phytosterols (brassicasterol, campesterol, stigmasterol and β-sitosterol)
and three tocopherols (alpha, gamma and delta). Both ultracentrifugation parameters and entrapment
efficiencies were determined by analyzing bioactive using LC-MS/MS. The separation of the liposomes
during ultracentrifugation was time-dependent. Relatively low amounts of liposomes sedimented after
30 min (around 80% for all bioactives) of ultracentrifugation, whereas high sedimentation of liposomes
was observed at 60, 90 and 120 min. There was no significant difference in sedimentation at 60, 90 and
120 min of ultracentrifugation. This supports the notion that after 60 min of ultracentrifugation at RPM
32,000 (G-force of 138000), a significant amount of liposomes was sedimented, leaving free bioactives
in the supernatant.
The optimum entrapment efficiencies of phytosterols and tocopherols into the liposomes obtained
by the thin film hydration homogenization, thin film hydration ultra-sonication and Mozafari method is
shown in Table 2. The results demonstrate that all three methods resulted in entrapment efficiency > 89%
for phytosterols and tocopherols. Table 2 does not show any specific pattern in entrapment efficiency
for bioactives. For example, in case of thin film hydration homogenization method, brassicasterol
showed the highest entrapment efficiency among all phytosterols; however, in the case of the Mozafari
method, brassicasterol has the lowest entrapment efficiency. Similarly, the Mozafari method showed
the highest entrapment efficiency for gamma tocopherols among all tocopherols. On the other hand,
thin film hydration ultrasonication showed the lowest entrapment efficiency for gamma tocopherol.
Thus, no concrete conclusion was obtained regarding entrapment differences between these bioactives.
The entrapment efficiency of some of lipophilic compounds were reported to be almost close to
100% [74,75]. However, Table 2 shows EE in the range of 89–97% for various bioactives, evaluated
in our work. It is possible that some of the liposomes were too small and failed to sediment during
ultracentrifugation. This will lead to decreased EE (the amount of bioactives in the sediment were
taken as a basis to calculate EE). Nevertheless, the obtained EE (shown in Table 2) is consistent with
entrapment efficiency of nutraceuticals such as vitamin E, resveratrol and retinol specified in the
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literature [57,65,76]. High entrapment efficiency, that is, greater than 85% is considered economical for
industrial application because it eliminates the cost of separating free and entrapped bioactives that
will be required in case of low entrapment efficiency.Pharmaceutics 2019, 11, x 8 of 17 
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in the range of 89–97% for various bioactives, evaluated in our work. It is possible that some of the 
Figure 3. LC-MS/MS chromatogram of tocopherols: 1-δ tocopherol, 2-γ tocopherol, 3-α tocopherol;
and phytosterols: 4-brassicasterol, 5-campesterol, 6-stigmasterol and 7-β-sitosterol. A-Rac tocol and
B-cholestanol are internal standard.
Table 2. Entrapment efficiency of bioactives (phytosterols and tocopherols) into liposomes prepared by
the thin film hydration homogenization, thin film hydration ultra-sonication and Mozafari method
expressed as mean ± standard deviation.
Methods
Entrapme t Efficiency (EE %)
Brassicasterol Campesterol β-Sitosterol AlphaTocopherol
G ma
Tocopherol
Delta
Tocopherol
Thin film hydration-Homogenization 95.9 ± 1.7 94.0 ± 2.2 94.8 ± 3.0 91.6 ± 2.4 90.5 ± 2.9 91.6 ± 3.6
Thin film hydration-Ultrasonication 91.5 ± 2.4 92.3 ± 3.4 90.1 ± 1.9 91.2 ± 2.1 89.8 ± 3.1 90.1 ± 2.3
Mozaf ri ethod 89.4 ± 2.8 93.7 ± 6.0 93.1 ± 6.0 92.3 ± 7.5 97.4 ± 1.9 95.3 ± 1.4
5.3. Effect of Lyophilization on the Physicochemical Properties
Freeze-drying of liposomes resulted in the increment in particle size, reaching up to 500 nm
(Figure 4). Various food compatible cryoprotectants such as sucrose, mannitol and lactose can be
used to address this issue [77]. Thus, food compatible sucrose was tested as a cryoprotectant [56].
The addition of sucrose maintained the desired particle size (Figure 4). The lyophilized liposomes
were then incorporated into model orange juice. Lyophilization is one of the crucial steps used for
stabilization of liposomes [78]. It extends the shelf life of liposomes and can prevent thermosensitive
bioactives from degradation [78].
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Figure 4. Effect of addition of sucrose as a cryo-protectant on particle size of liposomes before and after
lyophilization expressed as mean± standard deviation where * represents statistical significant (*p < 0.05)
in particle size after lyophilization in comparison to before lyophilization and after lyophilization in
presence of sucrose.
5.4. Chemical Sta il
Pasteurizati i e did not compromise the stability of bioactives as shown in Table 3.
There was no signific t i t e C- S/MS response for pasteurized and on-pasteurized
formulations, ra gi g fro 0.5 to 2.59 (Table 3). This shows that exposure to temperature of 72 ◦C
for short time of 15 s does not degrade bioactives entrapped within liposomes in the model juice
Table 3. Relative change in the concentration (represented by area under curve, AUC) of phytosterols
and tocopherol before and after pasteurization.
Bioactives AUC of Non-PasteurizedBioactives
AUC of Pasteurized
Bioactives
Perce tage Relative Change in AUC (%)
of Pasteurized and Non-Pasteurized
Brassicasterol 5.63 × 106 5.60 × 106 0.53
Campesterol 2.32 × 107 2.26 × 107 2.59
β-sitosterol 3.40 × 106 3.37 × 106 0.88
α-tocopherol 2.76 × 107 2.72 × 107 1.45
γ-tocopherol 4.94 × 106 4.89 × 106 1.01
δ-tocopherol 4.84 × 106 4.73 × 106 2.27
5.5. Physical Stability Studies
Both pasteurized and non-pasteurized liposomes in model orange juice showed similar trend in
particle size (Figure 5). This implies that high temperature in HTST pasteurization process did not
compromise the stability of the liposomes. Further, particle size of vesicle did not change significantly
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during the one-month storage at 4 ◦C (Figure 5). This shows that liposomal orange juice can be stored
in 4 ◦C for a month with adequate stability. Regarding zeta potential, unlike liposomes in purified
water, liposomal model juice was found to have positive zeta potential in the range of 5.6–8.9 mV.
Even though this zeta potential value is generally considered an indicator of instability to the colloidal
system [71], liposomal model orange juice showed adequate storage stability. Probably, the optimized
smaller vesicular size maintained the stability of particles preventing its aggregation.
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6. Conclusions
To address the lipophilicity, heat and light sensitivity challenges, unilamellar liposomes containing
phytosterols obtained from CODD and tocopherols were formulated and were applied to develop
a functional juice. Three different formulation approaches were employed and were compared for
their suitability in formulating phytosterols and tocopherols. All three methods showed optimum
physicochemical properties and excellent entrapment efficiencies that were greater than 89%. Mozafari
method was found to be simple and quick for formulating liposomes; however, the use of high
temperature can possibly degrade thermosensitive bioactives. In addition, its low B/L ratio (not
economical for scaling up) makes the Mozafari method less suitable method for phytosterols
and tocopherols in comparison to thin film hydration ultrasonication and thin film hydration
homogenization method. Both ultrasonication and homogenization seemed to be equally suitable
at a laboratory scale. At an industrial scale, however, the homogenization method is more feasible
due to the availability of homogenizers of large capacity. Thus, thin film hydration-homogenization
seems to be the best method for scaling-up the liposomal formulation containing phytosterols and
tocopherols. The pasteurization technique did not affect the chemical stability of tested bioactives.
Pharmaceutics 2019, 11, 185 12 of 16
Moreover, model orange juice containing liposomes maintained an adequate physical stability during
a period of one-month storage at 4 ◦C. In the future, liposomes containing phytosterols will be tested
for cholesterol-lowering efficacy by conducting animal and human trials.
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LDL Low-density lipoprotein
CODD Canola oil deodorizer distillate
POPs Phytosterol oxidation products
LC-MS/MS Liquid Chromatography Tandem Mass Spectrometry
PC Phosphatidylcholine
TEM Transmission electron Microscopy
HTST High temperature short time
B/L Bioactive/lipid
RPM Revolution per minute
%EE percentage entrapment efficiency
DLS Dynamic light scattering
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